Christopher C. Beyrer, MD, MPH, an internationally recognized epidemiologist who has worked on the front lines of HIV/AIDS and COVID-19 treatment and research, will be the next director of the Duke Global Health Institute (DGHI).

Biochemistry PhD students tutor high school students in the Emily Krzyzewski Center's Scholars to College program.

A team led by researchers at the Duke Cancer Institute identified a potential new tactic to disrupt the repair mechanism that cancer cells use after treatment, blunting their ability to regenerate. The approach could present a new treatment strategy.

One of Dr. Kimberly Johnson’s earliest memories of arriving at Duke for her residency in 1997 is the long hallways lined with portraits of white men. Johnson, professor of medicine, has since earned her own place in the hallowed halls of Duke—and beyond.

Dr. Ehsan Samei explores new ways to use medical imaging to improve the lives of patients.

Orthopaedic surgery has been labeled “the whitest specialty.” But Erica Taylor, MD, is changing perceptions as Duke’s first Black female orthopaedic surgeon. And in her role as a diversity, equity, and inclusion leader at Duke, she’s working to eliminate inequalities and open doors for future health care leaders.

On Friday, March 18, 2022, fourth-year medical students at Duke opened their envelopes and learned where in the country they will complete residency training. The ceremony took place in person this year at Trent Semans Center for Health Education, after two years of virtual ceremonies. Students are headed to some of the nation’s most prestigious residency programs, with 27 matching at Duke.

SFI St Patrick’s Day Science Medal is awarded annually to U.S.-based scientists, engineers or technology leaders with strong Irish connections, as chosen by an independent selection committee, to recognise their significant contributions to academia and industry and their roles in supporting and engaging with the research ecosystem in Ireland.

In a study that upends current concepts of immunotherapies for breast cancer, researchers at Duke Cancer Institute have described a newly identified process for how the drug pertuzumab works in tandem with trastuzumab.  

The difference between a social butterfly and a lone wolf is actually at least eight differences, according to new findings by a team of Duke brain researchers.